Trials / Terminated
TerminatedNCT00767494
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the IOP lowering efficacy of Travoprost/Brinzolamide dosed daily in the morning or evening, vs TRAVATAN dosed once daily in the evening, and vs. AZOPT dosed BID in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost/Brinzolamide fixed combination | Eye Drops, suspension once daily |
| DRUG | Azopt | Eye Drop Suspension, 1 drop BID |
| DRUG | Travatan | Eye Drop Solution, 1 drop BID |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-10-07
- Last updated
- 2012-09-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00767494. Inclusion in this directory is not an endorsement.